- October 14, 2016
First annual Harvard FUSION symposium assembles leaders at the convergence of science and business
- April 27, 2016
Five research projects with commercial potential receive sustaining funding through Harvard’s Physical Sciences & Engineering Accelerator.
- August 19, 2015
Twelve advanced research projects aimed at developing new therapies and diagnostics receive support in 2015-16 from Harvard’s Blavatnik Biomedical Accelerator.
- March 04, 2015
NEWTON, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis Venture Fund, Gurnet Point Capital, Roche Ventures, and SROne. The financing follows a worldwide license agreement between Harvard's Office of Technology Development and the company, providing exclusive rights to the technology.
Professor Jennifer Lewis discusses her revolutionary work in 3D printing, her entrepreneurial goals, and what is next on the horizon.
Page 3 of 5